novo nordisk semaglutide copycat risk asks FDA to block compounding pharmacies from making Ozempic copycats Novo Nordisk: How Ozempic Maker

Insurance denials represent another overlooked costpatients denied coverage must pay full retail prices anyway, often exceeding $900 per month for branded versions

Wegovy is indicated for adults with an initial body mass index (BMI) of 30 kg/m (obesity), or 27 kg/m (overweight) in the presence of at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease

doi: 10.1093/brain/awad003

Id say we are surprised, but Id be lying like a 5 year old that just left the cookie jar wide open after a sugar heist

Infertility affects roughly 30 to 50% of those diagnosed

This means that the results would vary from one individual to the next in both quality and quantity